Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
Fang Cui, Wenjia Zhu, Zhibin Zhou, Yuting Ren, Yifan Li, Mao Li, Yunyun Huo, Xusheng Huang Department of Neurology, Chinese PLA General Hospital, Beijing, People’s Republic of China Objectives: To examine the frequency and risk factors of cognitive and anxiety-depressive disorders in pat...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8e226a7dd074488ab5183c449da4aa5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c8e226a7dd074488ab5183c449da4aa5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c8e226a7dd074488ab5183c449da4aa52021-12-02T07:45:53ZFrequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease1178-2021https://doaj.org/article/c8e226a7dd074488ab5183c449da4aa52015-11-01T00:00:00Zhttps://www.dovepress.com/frequency-and-risk-factor-analysis-of-cognitive-and-anxiety-depressive-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Fang Cui, Wenjia Zhu, Zhibin Zhou, Yuting Ren, Yifan Li, Mao Li, Yunyun Huo, Xusheng Huang Department of Neurology, Chinese PLA General Hospital, Beijing, People’s Republic of China Objectives: To examine the frequency and risk factors of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). Methods: This was an observational study of 100 ALS/MND patients treated at our hospital outpatient and inpatient departments between January 2009 and April 2010 and 100 matched healthy controls. Subjects were surveyed using Mini Mental State Examination (MMSE), Zung Self-Rating Anxiety Scale (SAS), and Zung Self-Rating Depression Scale (SDS). Patient neurological status was graded by the ALS Functional Rating Scale (ALSFRS). Multivariate linear regression was used to identify factors associated with the MMSE, SAS, SDS, and ALSFRS scores. Results: Patients had significantly lower MMSE scores than controls (P<0.05). MMSE score did not differ by sex or age (<50/≥50 years) (P>0.05). Patients with higher educational level (college and above), shorter disease course (<2 years), and lower ALSFRS score (<20) had significantly higher MMSE scores (all P<0.05). Multivariate analysis revealed that higher education, shorter disease course, and lower ALSFRS score were independent predictors of better cognitive function (higher MMSE score). Patients had significantly higher mean SAS and SDS total scores than controls (both P<0.05), indicating higher subjective anxiety and depression. Female patients, patients with higher education, and those with higher ALSFRS scores had significantly higher SAS and SDS scores (all P<0.05). Age, occupation, diagnostic classification, disease duration, and disease awareness did not influence SAS or SDS scores. Multivariate analysis indicated that lower education and lower ALSFRS were protective factors against anxiety and depression. Conclusion: The frequency of anxiety-depressive disorders was high among patients with ALS/MND. High educational level, short course of disease, and lower ALSFRS were associated with preserved cognitive function. Female sex, higher education, and lower ALSFRS score conferred a greater risk of anxiety and depression. Tailored pharmacotherapy and psychological interventions may help in reducing anxiety and depression in these patients. Keywords: motor neuron disease, amyotrophic lateral sclerosis, cross-sectional study, anxiety, depressionCui FZhu WJZhou ZBRen YLi YFLi MHuo YYHuang XSDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 2847-2854 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Cui F Zhu WJ Zhou ZB Ren Y Li YF Li M Huo YY Huang XS Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease |
description |
Fang Cui, Wenjia Zhu, Zhibin Zhou, Yuting Ren, Yifan Li, Mao Li, Yunyun Huo, Xusheng Huang Department of Neurology, Chinese PLA General Hospital, Beijing, People’s Republic of China Objectives: To examine the frequency and risk factors of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). Methods: This was an observational study of 100 ALS/MND patients treated at our hospital outpatient and inpatient departments between January 2009 and April 2010 and 100 matched healthy controls. Subjects were surveyed using Mini Mental State Examination (MMSE), Zung Self-Rating Anxiety Scale (SAS), and Zung Self-Rating Depression Scale (SDS). Patient neurological status was graded by the ALS Functional Rating Scale (ALSFRS). Multivariate linear regression was used to identify factors associated with the MMSE, SAS, SDS, and ALSFRS scores. Results: Patients had significantly lower MMSE scores than controls (P<0.05). MMSE score did not differ by sex or age (<50/≥50 years) (P>0.05). Patients with higher educational level (college and above), shorter disease course (<2 years), and lower ALSFRS score (<20) had significantly higher MMSE scores (all P<0.05). Multivariate analysis revealed that higher education, shorter disease course, and lower ALSFRS score were independent predictors of better cognitive function (higher MMSE score). Patients had significantly higher mean SAS and SDS total scores than controls (both P<0.05), indicating higher subjective anxiety and depression. Female patients, patients with higher education, and those with higher ALSFRS scores had significantly higher SAS and SDS scores (all P<0.05). Age, occupation, diagnostic classification, disease duration, and disease awareness did not influence SAS or SDS scores. Multivariate analysis indicated that lower education and lower ALSFRS were protective factors against anxiety and depression. Conclusion: The frequency of anxiety-depressive disorders was high among patients with ALS/MND. High educational level, short course of disease, and lower ALSFRS were associated with preserved cognitive function. Female sex, higher education, and lower ALSFRS score conferred a greater risk of anxiety and depression. Tailored pharmacotherapy and psychological interventions may help in reducing anxiety and depression in these patients. Keywords: motor neuron disease, amyotrophic lateral sclerosis, cross-sectional study, anxiety, depression |
format |
article |
author |
Cui F Zhu WJ Zhou ZB Ren Y Li YF Li M Huo YY Huang XS |
author_facet |
Cui F Zhu WJ Zhou ZB Ren Y Li YF Li M Huo YY Huang XS |
author_sort |
Cui F |
title |
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease |
title_short |
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease |
title_full |
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease |
title_fullStr |
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease |
title_full_unstemmed |
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease |
title_sort |
frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/c8e226a7dd074488ab5183c449da4aa5 |
work_keys_str_mv |
AT cuif frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease AT zhuwj frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease AT zhouzb frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease AT reny frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease AT liyf frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease AT lim frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease AT huoyy frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease AT huangxs frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease |
_version_ |
1718399185116463104 |